Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Beldex has made itself a pioneer in privacy-targeted blockchain solutions. Its ecosystem consists of capabilities just like ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...

In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price ...

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $243.45 which represents a slight increase of $2.98 or 1.24% from the prior close of $240.47. The stock opened at $239 and ...

BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price hoisted by analysts at Piper Sandler from $275.00 to $280.00 in a research report issued on Tuesday,Benzinga reports.

Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm ...

Exchange Traded Concepts LLC reduced its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 3.5% during ...

In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...

BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...